Neonatal Clinical Pharmacology
Author Contributions
Funding
Conflicts of Interest
List of Contributions
- Giger, E.V.; Tilen, R. Comment on Shaniv et al. Neonatal drug formularies—A global scope. Children 2023, 10, 1802.
- Shaniv, D.; Smits, A.; Allegaert, K.; on behalf of the Neonatal Drug Formularies Group. A Callout for international collaboration. Reply to Giger, E.V.; Tilen, R. Comment on “Shaniv et al. Neonatal drug formularies—A global scope”. Children 2023, 10, 1803.
- Agakidou, E.; Chatziioannadis, I.; Kontou, A.; Stathopoulou, T.; Chotas, W.; Sarafidis, K. An update on pharmacological management of neonatal hypotension: When, why, and which medication. Children 2024, 11, 490.
- Stathopoulou, T.; Agakidou, E.; Paschaloudis, C.; Kontou, A.; Chatzioannidis, I.; Sarafidis, K. Strong association between inotrope administration and intraventricular hemorrhage, gestational age, and the use of fentanyl in very low gestational age infants: A retrospective study. Children 2023, 10, 1667.
- Singu, B.S.; Verbeeck, R.K.; Pieper, C.H.; Ette, E.I. Confirming the suitability of a gentamicin dosing strategy in neonates using the population pharmacokinetic approach with truncated sampling duration. Children 2024, 11, 898.
References
- Ward, R.M.; Benjamin, D.; Barrett, J.S.; Allegaert, K.; Portman, R.; Davis, J.M.; Turner, M.A. Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates. Pediatr. Res. 2017, 81, 692–711. [Google Scholar] [CrossRef] [PubMed]
- Shaniv, D.; Bolisetty, S.; Young, T.E.; Mangum, B.; Ainsworth, S.; Elbers, L.; Schultz, P.; Cucchi, M.; de Wildt, S.N.; van der Zanden, T.M.; et al. Neonatal Drug Formularies—A Global Scope. Children 2023, 10, 848. [Google Scholar] [CrossRef] [PubMed]
- De Hoop-Sommen, M.A.; van der Zanden, T.M.; Allegaert, K.; Flint, R.B.; Simons, S.H.P.; de Wildt, S.N. Working group neonatal pharmacology (NeoDose project). Neonatology 2023, 120, 196–207. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Allegaert, K.; Yalcin, N.; Flint, R.B.; Simons, S.H.P. Neonatal Clinical Pharmacology. Children 2024, 11, 1102. https://doi.org/10.3390/children11091102
Allegaert K, Yalcin N, Flint RB, Simons SHP. Neonatal Clinical Pharmacology. Children. 2024; 11(9):1102. https://doi.org/10.3390/children11091102
Chicago/Turabian StyleAllegaert, Karel, Nadir Yalcin, Robert B. Flint, and Sinno H. P. Simons. 2024. "Neonatal Clinical Pharmacology" Children 11, no. 9: 1102. https://doi.org/10.3390/children11091102